Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16306208rdf:typepubmed:Citationlld:pubmed
pubmed-article:16306208lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16306208lifeskim:mentionsumls-concept:C0848558lld:lifeskim
pubmed-article:16306208lifeskim:mentionsumls-concept:C0253596lld:lifeskim
pubmed-article:16306208pubmed:issue6lld:pubmed
pubmed-article:16306208pubmed:dateCreated2005-11-24lld:pubmed
pubmed-article:16306208pubmed:abstractTextHypospadias is a congenital anomaly of the genitalia characterized by abnormalities of the urethra and foreskin, with the urethral meatus located in an abnormal position anywhere from the distal ventral penile shaft to the perineum. Because the incidence of hypospadias is approximately 1/200-1/300 live male births, it is one of the most common congenital malformations, but its etiology is largely uncharacterized. Genomic analysis of hypospadic tissue indicated a potential role for activating transcription factor 3 (ATF3) in the development of this anomaly. ATF3 may be involved in homeostasis, wound healing, cell adhesion, or apoptosis, and normally it is expressed at a steady-state in quiescent cells. Additionally, it has been shown to be an estrogen-responsive gene, and the etiology of hypospadias may be related to in utero exposure to estrogenic or anti-androgenic compounds. We examined the expression of ATF3 in tissues from 28 children with hypospadias compared with 20 normal penile skin tissue samples from elective circumcision. Eighty-six percent of the hypospadias samples were immunohistochemically positive, compared with 13% of normal tissue samples. Seventy-five percent of hypospadias samples were positive from in situ hybridization, compared with 1% of circumcision samples. Our results indicate that ATF3 is up-regulated in the penile skin tissues of boys with hypospadias, suggesting a role for this transcription factor in the development of this abnormality. Because the etiology of hypospadias may include exposure to estrogenic compounds, the responsiveness of ATF3 to estrogen is also discussed.lld:pubmed
pubmed-article:16306208pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16306208pubmed:languageenglld:pubmed
pubmed-article:16306208pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16306208pubmed:citationSubsetIMlld:pubmed
pubmed-article:16306208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16306208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16306208pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16306208pubmed:statusMEDLINElld:pubmed
pubmed-article:16306208pubmed:monthDeclld:pubmed
pubmed-article:16306208pubmed:issn0031-3998lld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:BaskinLaurenc...lld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:LinGuitingGlld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:WangZhongZlld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:LiuBenchunBlld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:WillinghamEmi...lld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:AgrasKorayKlld:pubmed
pubmed-article:16306208pubmed:authorpubmed-author:EbbersMichele...lld:pubmed
pubmed-article:16306208pubmed:issnTypePrintlld:pubmed
pubmed-article:16306208pubmed:volume58lld:pubmed
pubmed-article:16306208pubmed:ownerNLMlld:pubmed
pubmed-article:16306208pubmed:authorsCompleteYlld:pubmed
pubmed-article:16306208pubmed:pagination1280-3lld:pubmed
pubmed-article:16306208pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:meshHeadingpubmed-meshheading:16306208...lld:pubmed
pubmed-article:16306208pubmed:year2005lld:pubmed
pubmed-article:16306208pubmed:articleTitleActivating transcription factor 3 is up-regulated in patients with hypospadias.lld:pubmed
pubmed-article:16306208pubmed:affiliationCenter for the Study and Treatment of Hypospadias, Department of Urology, University of California, San Francisco 94143, USA.lld:pubmed
pubmed-article:16306208pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16306208pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:16306208pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:467entrezgene:pubmedpubmed-article:16306208lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16306208lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16306208lld:pubmed